Exempts any covered substance use disorder and mental health treatment services and all FDA approved medications for the treatment of substance use disorder, HIV, hepatitis C and mental health conditions, from all recipient restriction program coverage and payment restrictions.
- Chamber
- Senate
- Introduced
- May 15, 2025
- Last action
- Jun 1, 2026 — REFERRED TO HEALTH
- Session
- 2025-2026
- Momentum
- 58 · Moderate